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Objective:    To explore the electrophysiological proper-
ties of differentiation of rat bone marrow-derived stromal
stem cells (rBMSCs) to neuron-like cells in vitro by
edaravone, a new type of free radical scavenger.
Methods:    Stromal stem cells were separated from rat
bone marrow with Ficoll-Paque reagent and expanded in
different culture medium in vitro. rBMSCs were induced by
edaravone containing serum-free L-DMEM. Morphologic
observation and Western blot analysis including the ex-
pression of Nav1.6, Kv1.2, Kv1.3, Cav1.2 were performed,
and whole patch-clamp technique was used.
Results:    Cyton contraction and long processes were
shown in differentiated stromal stem cells. Nav1.6, Kv1.2,
Kv1.3 and Cav1.2 were expressed in both differentiated and
undifferentiated cells. However, the expression of channel
proteins in differentiated cells was up-regulated.
Consistently, their resting potential and outward currents
were also enhanced in the differentiated cells, which was
especially significant in the outward rectifier potassium
current.
Conclusion:    In vitro, neuron-like cells derived from
rBMSCs, induced by edaravone, possess electrophysiologi-
cal properties of neurons.
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Bone marrow stromal stem cells (BMSCs) haveself-renewal and multi-lineage differentiationpotential. Under appropriate conditions, BMSCs
can give rise to a wide range of mature cell types, such
as osteoblasts, chondrocytes, myocytes and adipocytes.1-4
In recent years, it was reported that BMSCs could dif-
ferentiate into neuron-like cells by a way of cross-
mesoderm.5 Owing to its rapid expansion, ease to
obtain,  autologous t ransplantat ion and low
immunogenicity, BMSCs are increasingly becoming the
focus in the field of tissue engineering. At present, main
inductive reagents of neural differentiation in BMSCs
are anti-oxidants and cytokines. Preliminary studies
showed that edaravone, a new type of oxygen free radi-
cal scavenger, was capable of protecting neurons,6 and
widely used to treat several clinical diseases such as acute
ischemic cerebral infarction and spinal cord injury.7-8 This
experimental study aimed to explore electrophysiologi-
cal characteristics of neuronal differentiation in rBMSCs
induced by edaravone in vitro, which would be not only
beneficial for studying the mechanism of nerve cell
development, but also for laying substantial theoretical
foundation for the treatment of spinal cord injury and
other nervous system diseases.
METHODS
Animals
Male Spraque-Dawiey rats, weighing 120 -150 g,
were purchased from the Experimental Animal Center
of Guangdong Medical College.
Reagents and instruments
Dulbecco’s modified Eagle’s medium (DMEM) with
low glucose and fetal calf serum was purchased from
Life Technologies (Invitrogen, USA). Ficoll-Paque sepa-
ration medium (1.077×103g/L) was obtained from
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Pharmacia Corporation (New Jersey, USA). BDNF and
NGF were purchased from Peprotech (New Jersey, USA).
Edaravone was purchased from Simcere (Nanjing,
China).Rabbit anti-Kv1.2, anti-Kv1.3, anti-Cav1.2 and
anti-Nav1.6 were obtained from Chemicon (Temecula,
USA). Goat anti-rabbit IgG (H+L) and chemilumines-
cent substrate were purchased from KPL (Gaithersburg,
USA). Rabbit anti- GAPDH mAb was obtained from
Proteintech Group, Inc. (Chicago, USA). 0.25% trypsin,
0.02% EDTA, bFGF, penicillin, streptomycin, tetraethy-
lammonium (TEA), 4-amino-pyridine (4-AP), tetrodot-
oxin (TTX), nifedipine and clotrimazole were purchased
from Sigma (Santa Clara, USA).
Separation and culture of rBMSCs
 Under aseptic conditions, rat bone marrow cells
were diluted from bilateral femurs with media contain-
ing DMEM, 20% fetal bovine serum, 2 mmol/l glutamine,
100 U/ml penicillin and 100 µg/ml streptomycin. Cell
suspension was gently overlayed to Ficoll-Paque sepa-
ration medium at a density of 1.077×103 g/L. After cen-
trifugation for 30 minutes at a speed of 2500 r/min, mono-
nuclear cell layer was collected, and then re-suspended
with DMEM, centrifuging about 4 minutes at a speed of
1500 r/min. The supernatant was discarded. Mono-
nuclear cells collected were cultured in T-25 flasks at a
density of 2×10 6 cells/ml. The cells were put into 37°C
incubator with saturated humidity, 95% air and 5% CO2.
These media were replaced every 2-3 days, and after
the cultured cells reached confluence, passage was
performed.
Flow cytometry
For flow cytometer examination, the adherent cells
from the fifth passage were trypsinized and resuspended
in PBS solution containing 1% bovine serum albumin.
Approximately 1×106 cells were incubated with mono-
clonal antibodies against CD29, CD34, CD44, CD45
and CD105 for 30 minutes at 4°C. These monoclonal
antibodies were conjugated wi th f luorescein
isothiocyanate (FITC) or phycoerythrin (PE). Each fluo-
rescence analysis included the appropriate FITC- or PE-
conjugated isotope antibody controls. Cells were ana-
lyzed using a FAC scan laser flow cytometry system
(Becton-Dickinson) equipped with a Macintosh
PowerMac G3 personal computer (Apple Computers
Inc., Cupertino, USA) and Cell Quest (Becton-
Dickinson, USA) software.
Neuronal differentiation
 The methods used in this study were improved in
the light of previous reports.9-11 The passage 5 cells were
plated in 6-well plate plus round cover slips coated with
poly-D-lysine at a density of 2500 cells/cm2.The ex-
periment was composed of two groups including con-
trol and edaravone. The control group was maintained
only in DMEM/20% FBS, while the media of treatment
groups, twenty-four hours prior to neuronal induction,
were replaced with preinduction media consisting of
DMEM, 20% FBS and 10ng/ml bFGF. To initiate neu-
ronal differentiation, the preinduction media were
removed, and the cells were washed with PBS and re-
spectively transferred to neuronal induction media com-
posed of DMEM/ 20 µg/ml edaravone. After 6 hours
induction, cells were studied by Western blot. To ex-
plore characteristics of the functional ionic currents,
the differentiated cells were continuously cultured with
BDNF&NGF at a final concentration of 50 ng/ml for 14
days.
Western blot
Western blot analysis of membrane protein expres-
sion levels was performed on undifferentiated rBMSCs
and neuronal differentiated rBMSCs. Primary antibodies
of ion channels were used in the detection of protein
expression. The cultured cells were rinsed with PBS and
then lysed for 30 minutes on ice using RIPA-B buffer (0.5%
Nonidet P-40, 20 mmol Tris, pH 8.0, 50 mmol NaCl, 50
mmol NaF, 100 µmol Na3VO4, 1 mmol DTT, and 50 µg/ml
PMSF). The lysate was centrifuged at 12 000 r/min for 20
minutes at 4°C; the pellet was discarded and the su-
pernatant was subjected to a 4%-8% gradient acrylamide
gel and electrophoretically transferred to a PVDF
membrane. The blots were blocked in TBS containing
5% BSA and 0.05% Tween 20. The membrane was incu-
bated at 4°C overnight with primary antibodies, washed
extensively in TBS containing 0.05% Tween 20 and then
treated with a secondary antibody conjugated horserad-
ish peroxidase for 1 hour. The blots were subsequently
detected by electrochemiluminescence.
Electrophysiological recordings
Electrophysiological recordings were conducted as
described previously at room temperature (20-24°C).12
In brief, whole-cell patch-clamp configuration was used
to record electrical activity with a List EPC-7 patch
clamp amplifier (List Electronic, Darmstadt, Germany),
a laboratory interface (CED 1401, Cambridge, UK) and
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EPC software (CED, Cambridge, UK). Data were fil-
tered at 3 KHz and sampled at 10 KHz. The patch-
clamp pipettes were made from standard wall borosili-
cate glass capillaries with an inner filament on a two-
stage vertical puller and gave a resistance of 4-6 MΩ
when filled with pipette solution. The junction potential
between the patch pipette and the bath solutions was
nulled just before forming the giga-seal by negative
suction. The cell membrane was ruptured by gentle
suction to establish the whole-cell configution. Cell
capacitance compensation and series resistance com-
pensation were used to minimize voltage errors. The
amplifier reading of capacitance was used as the value
for whole cell membrane capacitance. The cells on the
coverslips were perfused with external solution contain-
ing  NaCl 136 mmol/L, KCl 5.4 mmol/L, CaCl2 1.8 mmol/
L, MgCl2 1 mmol/L, HEPES 10 mmol/L, NaH2PO4 0.33
mmol/L and glucose 10 mmol/L (300 mmol/L, pH 7.4
adjusted by 1 mol NaOH). The patch electrodes were
filled with the solution containing K-Gluconate 120
mmol/L, KCl 20 mmol/L, MgCl2 1 mmol/L, EGTA 0.5
mmol/L, HEPES 10 mmol/L, Na-ATP 2 mmol/L, with
the pH 7.2 adjusted  with 1 mol KOH and the osmolar-
ity 300 mmol/L adjusted with sucrose. K+ in superfusion
and pipette solutions was replaced by equimolar Cs+
when K+-free conditions were applied for recording so-
dium current and L-type Ca2+ current.
Cell were held at -100 mV and stepped to +60 mV
in a step increment of 10 mV. Each step lasted for 300
ms and then maintained at -30 mV for 100 ms before
returning to the holding potential.
Statistical analysis
Data are presented as mean ± standard error (SEM).
Student’s t-test was used to analyze data and detect
statistically significant differences. Values of P<0.05
were considered statistically significant. All experiments
were repeated at least 3 times.
RESULTS
Morphological changes of rBMSCs
rBMSCs were observed under inverted microscope.
After 24-hour culture the cells were adherent to the bot-
tom of flask, proliferating after 72 hours.14 days later
scattered cells gradually integrated to form a single-
layer. After passage rBMSCs grew faster than primary
cells and reached confluence only about 3 days. Most
cells were spindle. These cells were distictively distin-
guished by highly refractive cell bodies with neuron-like
processes terminating in structures that resembled
growth cones after 6-hour induction.  After 14 days of
culture in neuronal maintenance of medium, most cells
presented with neuronal morphology including a small
cell body and long extensions.
Flow cytometry analysis of rBMSCs
Flow cytometry analysis revealed that cells at this
stage expressed CD29, CD105 and CD44, but not CD34
and CD45. The results indicated that rBMSCs were ca-
pable of self-renewal and pluripotentiality and that the
cells lost the expression of cell surface markers CD34/
CD45 associated with hematopoietic precursors (Fig.1).
Western blotting analysis
After 6-hour neuronal differentiation we examined
the protein expression of membrane channels. As
shown in Fig. 2, expression of Kv1.2, Kv1.3, Nav1.6
channels was dramatically increased. However, expres-
sion of Cav1.2 was nearly unchanged compared to the
control group.
Electrophysiological properties in rBMSCs
We chose typical neuron-like cells to analyse elec-
Fig. 1.  Flow cytometry analysis of rBMSCs.
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trophysiological properties by using whole patch-clamp
technique. In this study we found that differentiated cells
were dramatically increased compared with untreated
cells. The value of resting potential was (-24.2±5.3) mV
(n=26) and (-58.4±6.5) mV (n=19) respectively. The den-
sity of outward potassium currents in differentiated cells
also increased significantly. The data was shown in Table 1.
We determined if the increased voltage-activated
current in differentiated rBMSCs could be blocked by
potassium channel blockers. The rBMSCs were treated
with edaravone to induce neuronal differentiation and
cultured with BDNF&NGF for 2 weeks. Cells were sub-
sequently subjected to measurement of voltage-activated
current. Compared to the control (Fig 4, panel A&C),
currents detected in the treated cells were dramatically
increased (Fig. 5, panel A&C). The currents were sensi-
tive to potassium channel blockers including TEA and
clotrimazole (Fig. 4, panel B&D; Fig. 5, panel B&D).18.41 ± 3.61
54.38 ± 5.43*
Table 1. Current density in treated and control cells ( χ ± s)
Control
Edaravone
    Groups                         n                              pA/pf
14
19
*P<0.01, compared with control group. Statistical analysis of t-test
was used. pA means channel currents in different cells and pf
means the electric capacity.
Cells were held at -100 mV and stepped to +60 mV
in a step increment of 10 mV. Each step lasted for 300
ms and then maintained at -30 mV for 100 ms before
returning to the holding potential(Fig. 3C).In the undiffer-
entiated rBMSCs, three types of voltage-activated currents
were recorded, including a delayed rectifier current, a noise-
like current and a transient outward current (Fig. 3A&B).
The delayed rectified current was usually activated at po-
tentials between -10 mV and +20 mV. The noise-like cur-
rent was activated rapidly at potentials between +30 mV
and +60 mV (Fig. 3A). The transient outward current was
activated rapidly when stepped to the potentials between -
80mV and +60mV, but inactivated immediately when the
peak current was reached (Fig. 3B).
Fig. 4. Ion currents characteristics in control group.
Fig. 2. Expression of membrane channel proteins in control and
edaravone-treated cells.
Fig. 3. Electrophysiological recordings of voltage-activated cur-
rents and holding mode.
Fig. 5.  Ion currents characteristics in edaravone group.
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DISCUSSION
Repair of central neuronal damage and neuronal
regeneration has been a focus for neuroscience.
Recently, studies have shown that embryonic stem cells
(ESCs), neural stem cells (NSCs) and MSCs have the
potential to differentiate into neurons and can improve
neural function after being transplanted in animal mod-
els of nerve injury.13,14,15 However, obstacles to direc-
tional differentiation and clone purification, as well as
ethical and legal issues are presented in ESCs. In
addition, they are limited to use by its tumorigenicity.16
There are also limited resources for NSCs. Therefore,
rBMSCs are increasingly used as seed cells for treat-
ment of neuron-related diseases, due to their high po-
tential of self-renewal, easy to obtain, capable of multi-
directional differentiation, low immunogenicity and no
ethical restriction.
At present, antioxidant and cytokines are usually
used to induce MSCs to differentiate into neuron-like
cells. In this study, we used a free radical scavenger,
edaravone, to initiate neuronal differentiation in rBMSCs.
It has been shown that edaravone is a newly developed
antioxidative radical scavenger for the treatment of acute
cerebral infarction and other diseases, exerting
neuroprotective effects against ischemic insult.17, 18 In
our preliminary studies, we found that rBMSCs could
be differentiated into neuron-like cells with edaravone
treatment and expressed neuron-related antigen. In this
study, we detected ion channel proteins including Kv1.2,
Kv1.3, Nav1.6 and Cav1.2 by Western blot. Our results
suggest that sodium channels (Nav1.6), potassium chan-
nels (Kv1.2 and Kv1.3) and calcium channels (Cav1.2) were
up-regulated in the differentiated rBMSCs. Sodium and
potassium channels are the fundamental proteins that
are responsible for the signal conduction in neurons.
To study functional ionic channel currents in
rBMSCs, electrophysiological recordings were
performed. We found that the voltage-activated potas-
sium currents, including the delayed rectifier, the noise-
like and the transient outward K+ currents, were dra-
matically increased in the differentiated cells compared
with that in undifferentiated rBMSCs. Previous reports
from others suggest that a rise in delayed rectifier po-
tassium current is associated with the maturation of
cell excitability and neuronal differentiation.19 After 14
days continuously cultured with BDNF and NGF that
could promote neuron-like cells mature reported
previously,20 K+ current amplitude including delayed
rectifier potassium current was significantly higher than
that in control rBMSCs, suggesting that the treated
rBMSCs possess certain current properties in neurons.
However, TTX-sensitive rapid sodium currents and
nifedipine-sensitive calcium currents could not be de-
tected in the differentiated cells, although sodium chan-
nel proteins and calcium channel proteins are expressed
in the cells. There are two explanations for the contra-
dictive results. First, the differentiated neuronal cells
are not fully maturated neurons but rather to be in a
process of maturation and need further administration
by increasing concentration of BDNF and NGF, pro-
longing culture period or other ways. Second, sodium
channels are expressed and functioned in the treated
cell population, but not all the treated cells differentiate
into functional neurons. The recorded cells are not fully
functional.
In conclusion, our study demonstrates that differ-
entiated cells derived from rBMSCs by edaravone have
electrophysiological characteristics of neurons.
However, the mechanism of neuronal differentiation by
edaravone is unclear. It is essential to conduct in-depth
research to ensure the long-term safety and efficacy of
seed cells for treatment of neurological disorders such
as spinal injuries, cerebral infarction, etc.
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